SCHEMBL30278378

SCHEMBL30278378

CC(CC1CCCCC1)N(Cc1ccccc1NC(=O)c1ccccc1F)C(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 1/20 0.42
ALDH1A1 P00352 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
USP2 O75604 1/20 0.41
GLA P06280 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
ATM Q13315 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
LMNA P02545 3/20 0.40
NPY5R Q15761 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
RAB9A P51151 1/20 0.39
HTR2C P28335 1/20 0.38
SLC6A4 P31645 1/20 0.38
MAPT P10636 2/20 0.38
TP53 P04637 2/20 0.38
BCL3 P20749 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23004929 0.88 LMNA (0.42) USP30ALDH1A1L3MBTL1USP2GLA
SCHEMBL30278364 0.86 GPR119 (0.40) ALDH1A1L3MBTL1NPY5RMEN1KMT2A
SCHEMBL30278336 0.78 NPY5R (0.41) L3MBTL1ATMNPY5RHTR2CSLC6A4
SCHEMBL23022839 0.77 ATM (0.47) ALDH1A1L3MBTL1ATMLMNANPY5R
SCHEMBL23022944 0.77 LMNA (0.45) USP30ALDH1A1L3MBTL1USP2GLA
Hydrochloric Acid SCHEMBL23004941 0.76 LMNA (0.44) USP30ALDH1A1L3MBTL1USP2GLA
SCHEMBL30278355 0.75 NPY5R (0.39) TSHRATMNPSR1NPY5RHTR2C
SCHEMBL23004931 0.75 CTSK (0.45) USP30ALDH1A1L3MBTL1USP2GLA
SCHEMBL23004879 0.73 ALDH1A1 (0.41) ALDH1A1L3MBTL1ATMNPY5RMEN1
SCHEMBL30278360 0.72 BCHE (0.41) TSHRNPSR1NPY5RKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230102879-A1 TRNA SYNTHETASE INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2023-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230102879-A1 TRNA SYNTHETASE INHIBITORS TRMT1, AARS1, GARS1 USP30 1457/4885ALDH1A1 2254/4885L3MBTL1 229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.